Injective (INJ) is currently trading at $4.40, reflecting a slight increase of 0.52% over the last 24 hours. The daily price range has been tight, with a high of $4.49 and a low of $4.37, indicating limited volatility in the short term.

The volume over the past 24 hours stands at approximately $37.26 million, which accounts for 8.48% of the market capitalization, suggesting moderate trading activity. However, the recent price trends show a negative 7-day change of -6.78% and a significant decline over the last 14 days of -15.48%, highlighting a bearish sentiment.

Examining the moving averages, the 8, 13, and 21-period SMAs are all positioned below the current price, indicating potential resistance levels, while the 144 SMA is notably higher at $4.54, suggesting a longer-term bearish trend. The RSI values indicate that INJ is currently in a neutral zone; the 1-hour RSI at 42 shows mild bearish momentum, while the 7-day RSI at 47 reflects a lack of strong buying pressure.

Given the historical context, INJ's all-time high was $52.62, achieved in March 2024, which illustrates the potential for significant upside but also underscores the current downturn. With the recent negative price movements and resistance levels from the moving averages, the technical indicators suggest caution.

In conclusion, the current bearish trend coupled with the resistance levels and negative momentum signals a Hold rating for Injective (INJ). Investors should closely monitor for signs of reversal or improved buying interest before considering a Buy position.